PortfoliosLab logoPortfoliosLab logo
Valneva SE (VALN)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US92025Y1038
CUSIP
92025Y103
IPO Date
May 5, 2021

Highlights

Market Cap
$541.92M
Enterprise Value
$657.43M
EPS (TTM)
-$1.38
Total Revenue (TTM)
$174.66M
Gross Profit (TTM)
$67.52M
EBITDA (TTM)
-$72.22M
Year Range
$5.43 - $12.25
Target Price
$18.33
ROA (TTM)
-28.76%
ROE (TTM)
-108.06%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Valneva SE

Often compared with VALN:
VALN vs. RGTIVALN vs. MU

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Valneva SE, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Valneva SE (VALN) has returned -29.14% so far this year and -6.86% over the past 12 months.


Valneva SE

1D
0.97%
1M
-43.64%
YTD
-29.14%
6M
-48.77%
1Y
-6.86%
3Y*
-15.20%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since May 5, 2021, VALN's average daily return is +0.05%, while the average monthly return is +0.10%. At this rate, your investment would double in approximately 57.8 years.

Historically, 42% of months were positive and 58% were negative. The best month was Aug 2021 with a return of +85.4%, while the worst month was Sep 2022 at -45.7%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.

On a daily basis, VALN closed higher 46% of trading days. The best single day was Jun 21, 2022 with a return of +93.1%, while the worst single day was Sep 13, 2021 at -39.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20264.42%20.41%-43.64%-29.14%
202532.20%16.78%-0.59%-5.44%0.87%-11.41%29.63%20.41%37.85%-24.02%0.92%-5.72%101.74%
2024-21.40%-12.88%11.55%-5.93%21.73%-22.70%4.85%-0.41%-17.49%-6.46%-28.32%7.95%-57.84%
20235.36%-12.63%-12.47%-7.85%20.70%29.39%0.46%-5.66%-17.17%-1.55%1.93%-10.77%-18.48%
2022-38.62%-3.96%4.84%-24.12%-5.84%-7.38%-10.82%-8.17%-45.67%31.66%-3.82%-0.55%-77.09%
2021-1.63%1.42%8.46%85.44%-40.75%42.07%44.70%-14.00%110.19%

Benchmark Metrics

Valneva SE has an annualized alpha of 1.12%, beta of 1.04, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since May 06, 2021.

  • This stock participated in 199.82% of S&P 500 Index downside but only 80.64% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
1.12%
Beta
1.04
0.03
Upside Capture
80.64%
Downside Capture
199.82%

Return for Risk

Risk / Return Rank

VALN ranks 35 for risk / return — below 35% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


VALN Risk / Return Rank: 3535
Overall Rank
VALN Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
VALN Sortino Ratio Rank: 3939
Sortino Ratio Rank
VALN Omega Ratio Rank: 4141
Omega Ratio Rank
VALN Calmar Ratio Rank: 3232
Calmar Ratio Rank
VALN Martin Ratio Rank: 2929
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Valneva SE (VALN) and compare them to a chosen benchmark (S&P 500 Index).


VALNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.09

0.90

-0.99

Sortino ratio

Return per unit of downside risk

0.43

1.39

-0.95

Omega ratio

Gain probability vs. loss probability

1.07

1.21

-0.14

Calmar ratio

Return relative to maximum drawdown

-0.28

1.40

-1.68

Martin ratio

Return relative to average drawdown

-0.71

6.61

-7.31

Explore VALN risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Valneva SE doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Valneva SE. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Valneva SE was 94.52%, occurring on Dec 17, 2024. The portfolio has not yet recovered.

The current Valneva SE drawdown is 90.71%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.52%Nov 30, 2021767Dec 17, 2024
-53.13%Sep 8, 20219Sep 20, 202148Nov 26, 202157
-21.36%May 18, 20218May 27, 202161Aug 24, 202169
-10.02%Sep 1, 20212Sep 2, 20212Sep 7, 20214
-6.25%Aug 25, 20211Aug 25, 20212Aug 27, 20213

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Valneva SE over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Valneva SE is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for VALN relative to other companies in the Biotechnology industry. Currently, VALN has a P/S ratio of 3.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for VALN in comparison with other companies in the Biotechnology industry. Currently, VALN has a P/B value of 5.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items